EPOSINO 4000 IU/1ML/SYRINGE (REF)

Directions:
The contents of each pre-filled syringe are ready for injection and shod be administered subcutaneously or intravenously based on healthcare provider instructions.
Pack size:
1 pre-filled syringe containing Erythropoietin-Alpha, each syringe containing 4000 International Units (I.U.).
Active ingredients:
Erythropoietin-Alpha (4000 I.U. per syringe).
Dosage:
Administered via injection, typically subcutaneously or intravenously, under the supervision of a healthcare professional. Dosage and frequency are determined based on the patient’s condition, response to treatment, and other factors.
Mechanism of action:
Erythropoietin stimulates the production of red blood cells in the bone marrow, thereby increasing the body’s oxygen-carrying capacity.
Additional information:
it is commonly prescribed to patients with CKD undergoing dialysis or those not on dialysis but experiencing symptomatic anemia.
It is also used to treat anemia in patients receiving chemotherapy for cancer and those with HIV taking certain medications.
Regular monitoring of hemoglobin levels, blood pressure, and iron status is crucial during treatment.
Adverse effects may include hypertension, thrombosis, pure red cell aplasia, and seizures.
Patients should be educated about proper administration techniques and instructed to report any unusual symptoms to their healthcare provider.
it should be used cautiously in patients with uncontrolled hypertension or a history of seizures.
Keep out of reach of children.
Store according to manufacturer’s instructions, typically refrigerated and protected from light.
Unused portions of pre-filled syringes should be discarded properly according to healthcare facility protocols.
it is a prescription medication and should only be used under the guidance of a qualified healthcare professional.